HUMAN HOLDINGS CO., LTD. Translation
Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any discrepancy between this translated document and the original Japanese document, the latter shall prevail.
Summary of Consolidated Financial Results for the Three Months Ended June 30, 2022 (Based on Japanese GAAP)
August 10, 2022 | ||||
Company name: | Human Holdings Co., Ltd. | |||
Stock exchange listing: | Tokyo | |||
Stock code: | 2415 | URL https://www.athuman.com/ | ||
Representative: | Representative Director, President and CEO | Tomonari Sato | ||
Inquiries: | Director, Corporate Planning Division | Yasuhiro Sato | TEL 03-6846-8002 | |
Scheduled date to file Quarterly Securities Report: | August 10, 2022 | |||
Scheduled date to commence dividend payments: | - | |||
Preparation of supplementary material on quarterly financial results: | Yes | |||
Holding of quarterly financial results meeting: | No |
(Amounts less than one million yen are rounded down)
1. Consolidated financial results for the three months ended June 30, 2022 (from April 1, 2022 to June 30, 2022)
(1) Consolidated operating results (cumulative) | Percentages indicate year-on-year changes | ||||||||||||||||
Net sales | Operating profit | Ordinary profit | Profit attributable to | ||||||||||||||
owners of parent | |||||||||||||||||
Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | ||||||||||
Three months ended June 30, 2022 | 22,585 | 4.9 | 535 | (29.6) | 609 | (27.8) | 379 | (20.2) | |||||||||
Three months ended June 30, 2021 | 21,536 | 2.2 | 761 | (4.4) | 844 | 2.0 | 475 | 5.6 | |||||||||
Earnings per share | Diluted earnings per share | ||||||||||||||||
Yen | Yen | ||||||||||||||||
Three months ended June 30, 2022 | 34.90 | - | |||||||||||||||
Three months ended June 30, 2021 | 43.72 | - | |||||||||||||||
(2) Consolidated financial position | |||||||||||||||||
Total assets | Net assets | Equity ratio | |||||||||||||||
Millions of yen | Millions of yen | % | |||||||||||||||
As of June 30, 2022 | 45,493 | 13,664 | 30.0 | ||||||||||||||
As of March 31, 2022 | 46,320 | 13,625 | 29.4 | ||||||||||||||
2. Cash dividends | |||||||||||||||||
Annual dividends per share | |||||||||||||||||
1st quarter-end | 2nd quarter-end | 3rd quarter-end | Fiscal year-end | Total | |||||||||||||
Yen | Yen | Yen | Yen | Yen | |||||||||||||
Year ended March 31, 2022 | - | 0.00 | - | 30.50 | 30.50 | ||||||||||||
Year ending March 31, 2023 | - | ||||||||||||||||
Year ending March 31, 2023 (Forecast) | 0.00 | - | 32.50 | 32.50 |
3. Forecast of consolidated financial results for the year ending March 31, 2023 (from April 1, 2022 to March 31, 2023)
Percentages indicate year-on-year changes
Net sales | Operating profit | Ordinary profit | Profit attributable to | Earnings per share | |||||||
owners of parent | |||||||||||
Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | Yen | |||
Full year | 91,454 | 6.0 | 2,900 | 17.2 | 2,936 | 8.3 | 1,742 | 5.8 | 160.19 |
1
4. Notes
- Changes in significant subsidiaries during the three months ended June 30, 2022 (changes in specified subsidiaries resulting in the change in scope of consolidation):
- Application of special accounting methods for preparing quarterly consolidated financial statements:
No
No
(3) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements | |
Changes in accounting policies due to revisions to accounting standards and other regulations: | No |
Changes in accounting policies due to other reasons: | No |
Changes in accounting estimates: | No |
Restatement of prior period financial statements: | No |
(4) Number of issued shares (common shares)
Total number of issued shares at the end of the period (including treasury shares)
As of June 30, 2022 | 10,987,200 | shares | As of March 31, 2022 | 10,987,200 | shares | |
Number of treasury shares at the end of the period | ||||||
As of June 30, 2022 | 109,201 | shares | As of March 31, 2022 | 109,201 | shares | |
Average number of shares during the period (cumulative from the beginning of the fiscal year) | ||||||
Three months ended June 30, 2022 | 10,877,999 | shares | Three months ended June 30, 2021 | 10,877,999 | shares |
2
Quarterly consolidated financial statements
Consolidated balance sheets
(Thousands of yen) | |||
As of March 31, 2022 | As of June 30, 2022 | ||
Assets | |||
Current assets | |||
Cash and deposits | 25,496,356 | 25,307,508 | |
Notes and accounts receivable - trade, and contract assets | 10,484,625 | 9,930,854 | |
Merchandise | 709,725 | 649,478 | |
Supplies | 20,326 | 14,106 | |
Other | 1,035,863 | 1,141,369 | |
Allowance for doubtful accounts | (3,131) | (2,694) | |
Total current assets | 37,743,765 | 37,040,623 | |
Non-current assets | |||
Property, plant and equipment | 3,226,419 | 3,182,696 | |
Intangible assets | |||
Goodwill | 8,604 | 7,513 | |
Other | 1,175,685 | 1,198,593 | |
Total intangible assets | 1,184,289 | 1,206,106 | |
Investments and other assets | |||
Guarantee deposits | 2,108,622 | 2,091,381 | |
Other | 2,303,168 | 2,234,861 | |
Allowance for doubtful accounts | (245,342) | (261,958) | |
Total investments and other assets | 4,166,448 | 4,064,284 | |
Total non-current assets | 8,577,157 | 8,453,087 | |
Total assets | 46,320,923 | 45,493,710 | |
Liabilities | |||
Current liabilities | |||
Accounts payable - trade | 232,033 | 177,539 | |
Current portion of long-term borrowings | 3,212,476 | 3,319,076 | |
Contract liabilities | 10,289,761 | 8,881,827 | |
Accounts payable - other | 6,555,913 | 6,293,410 | |
Income taxes payable | 254,275 | 145,033 | |
Provision for bonuses | 868,345 | 465,348 | |
Asset retirement obligations | 1,079 | - | |
Other | 2,393,706 | 2,998,820 | |
Total current liabilities | 23,807,591 | 22,281,056 | |
Non-current liabilities | |||
Long-term borrowings | 7,631,917 | 8,268,244 | |
Provision for retirement benefits for directors (and other | 506,522 | 509,480 | |
officers) | |||
Asset retirement obligations | 355,387 | 356,449 | |
Other | 393,911 | 414,231 | |
Total non-current liabilities | 8,887,739 | 9,548,406 | |
Total liabilities | 32,695,331 | 31,829,462 |
3
(Thousands of yen) | |||
As of March 31, 2022 | As of June 30, 2022 | ||
Net assets | |||
Shareholders' equity | |||
Share capital | 1,299,900 | 1,299,900 | |
Capital surplus | 799,691 | 799,691 | |
Retained earnings | 11,620,385 | 11,668,199 | |
Treasury shares | (66,834) | (66,834) | |
Total shareholders' equity | 13,653,142 | 13,700,956 | |
Accumulated other comprehensive income | |||
Valuation difference on available-for-sale securities | 990 | 927 | |
Foreign currency translation adjustment | (28,540) | (37,635) | |
Total accumulated other comprehensive income | (27,550) | (36,707) | |
Total net assets | 13,625,592 | 13,664,248 | |
Total liabilities and net assets | 46,320,923 | 45,493,710 |
4
Consolidated statements of income (cumulative) and consolidated statements of comprehensive income (cumulative)
Consolidated statements of income (cumulative)
(Thousands of yen) | |||
Three months ended | Three months ended | ||
June 30, 2021 | June 30, 2022 | ||
Net sales | 21,536,737 | 22,585,869 | |
Cost of sales | 15,895,995 | 16,952,178 | |
Gross profit | 5,640,742 | 5,633,690 | |
Selling, general and administrative expenses | 4,879,692 | 5,097,816 | |
Operating profit | 761,049 | 535,874 | |
Non-operating income | |||
Interest income | 2,098 | 2,897 | |
Dividend income | 42 | 63 | |
Reversal of allowance for doubtful accounts | 32,752 | - | |
Subsidy income | 37,585 | 50,510 | |
Foreign exchange gains | 7,684 | 48,868 | |
Other | 19,324 | 19,887 | |
Total non-operating income | 99,489 | 122,228 | |
Non-operating expenses | |||
Interest expenses | 3,884 | 5,300 | |
Provision of allowance for doubtful accounts | - | 34,145 | |
Settlement payments | 3,828 | 814 | |
Commission expenses | 4,259 | 2,783 | |
Other | 3,738 | 5,198 | |
Total non-operating expenses | 15,710 | 48,241 | |
Ordinary profit | 844,828 | 609,861 | |
Extraordinary income | |||
Gain on sale of non-current assets | 518 | 7,000 | |
Gain on sale of shares of subsidiaries and associates | - | 28,335 | |
Total extraordinary income | 518 | 35,335 | |
Extraordinary losses | |||
Loss on retirement of non-current assets | 0 | 37 | |
Impairment losses | 37,343 | - | |
Total extraordinary losses | 37,343 | 37 | |
Profit before income taxes | 808,003 | 645,159 | |
Income taxes | 332,454 | 265,566 | |
Profit | 475,548 | 379,592 | |
Profit attributable to owners of parent | 475,548 | 379,592 |
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Human Holdings Co. Ltd. published this content on 18 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 August 2022 06:33:02 UTC.
